Specialty Overview

Best Hospitals for Alpha-1-Antitrypsin Deficiency in India

90 liver transplant & hpb hospitals in our India network are listed, across 5 cities (Mumbai, Delhi NCR, Bengaluru, Hyderabad, Chennai), accredited by JCI, NABH, ISO, NABL, with 51,822 beds combined.

90
Hospitals Listed
5
Cities
4.5
Avg. Rating
5
Accreditation Types
The Short Answer

This page lists the liver transplant & hpb hospitals in our directory offering Alpha-1-Antitrypsin Deficiency in India, including Nanavati Super Specialty Hospital, Apollo Hospitals, Medanta - The Medicity, Artemis Hospital and others. Hospitals are listed across Mumbai, Delhi NCR, Bengaluru, Hyderabad, Chennai. Each listing links through to the hospital's full profile page.

Ask us about alpha-1-antitrypsin deficiency in India

Share a few details and our care coordination team will get back to you with next steps.

Top Hospitals for Alpha-1-Antitrypsin Deficiency in India

🇮🇳 Nanavati Super Specialty Hospital

Mumbai, India 5 (12 reviews) 350 beds
Why consider this hospital?
5/5 rating from 12 reviews350 beds
Specialties & Accreditation
OncologyCardiac SurgeryNeurosciencesTransplantBariatrics
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering alpha-1-antitrypsin deficiency can be cared for by Nanavati Super Specialty Hospital's care team in Mumbai, India, from initial consultation through recovery. Nanavati Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.

5/5
Rating
1950
Established
350
Beds
Mumbai, India
Location
Apollo Hospitals

🇮🇳 Apollo Hospitals

New Delhi, India 4.9 (1240 reviews) 1,000 beds
Why consider this hospital?
4.9/5 rating from 1240 reviews1,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering alpha-1-antitrypsin deficiency can be cared for by Apollo Hospitals's care team in New Delhi, India, from initial consultation through recovery. Apollo Hospitals, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.

4.9/5
Rating
1983
Established
1,000
Beds
New Delhi, India
Location
Medanta - The Medicity

🇮🇳 Medanta - The Medicity

Gurgaon, India 4.9 (2150 reviews) 1,600 beds
Why consider this hospital?
4.9/5 rating from 2150 reviews1,600 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering alpha-1-antitrypsin deficiency can be cared for by Medanta - The Medicity's care team in Gurgaon, India, from initial consultation through recovery. Medanta - The Medicity, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.

4.9/5
Rating
2009
Established
1,600
Beds
Gurgaon, India
Location
Artemis Hospital

🇮🇳 Artemis Hospital

Gurgaon, India 4.9 (64 reviews) 750 beds
Why consider this hospital?
4.9/5 rating from 64 reviews750 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering alpha-1-antitrypsin deficiency can be cared for by Artemis Hospital's care team in Gurgaon, India, from initial consultation through recovery. Artemis Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.

4.9/5
Rating
2007
Established
750
Beds
Gurgaon, India
Location
Fortis Memorial Research Institute

🇮🇳 Fortis Memorial Research Institute

Gurgaon, India 4.8 (1100 reviews) 1,000 beds
Why consider this hospital?
4.8/5 rating from 1100 reviews1,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgeryBariatric SurgeryVascular Surgery
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering alpha-1-antitrypsin deficiency can be cared for by Fortis Memorial Research Institute's care team in Gurgaon, India, from initial consultation through recovery. Fortis Memorial Research Institute, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.

4.8/5
Rating
1996
Established
1,000
Beds
Gurgaon, India
Location
Kokilaben Dhirubhai Ambani Hospital

🇮🇳 Kokilaben Dhirubhai Ambani Hospital

Mumbai, India 4.8 (1800 reviews) 750 beds
Why consider this hospital?
4.8/5 rating from 1800 reviews750 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgeryBariatric SurgeryVascular Surgery
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering alpha-1-antitrypsin deficiency can be cared for by Kokilaben Dhirubhai Ambani Hospital's care team in Mumbai, India, from initial consultation through recovery. Kokilaben Dhirubhai Ambani Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.

4.8/5
Rating
2009
Established
750
Beds
Mumbai, India
Location
Tata Memorial Hospital

🇮🇳 Tata Memorial Hospital

Mumbai, India 4.8 (2500 reviews) 629 beds
Why consider this hospital?
4.8/5 rating from 2500 reviews629 beds
Specialties & Accreditation
OncologyCancer Center
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering alpha-1-antitrypsin deficiency can be cared for by Tata Memorial Hospital's care team in Mumbai, India, from initial consultation through recovery. Tata Memorial Hospital, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.

4.8/5
Rating
1941
Established
629
Beds
Mumbai, India
Location
Max Super Specialty Hospital

🇮🇳 Max Super Specialty Hospital

New Delhi, India 4.8 (1300 reviews) 500 beds
Why consider this hospital?
4.8/5 rating from 1300 reviews500 beds
Specialties & Accreditation
CardiacLiver Transplant
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering alpha-1-antitrypsin deficiency can be cared for by Max Super Specialty Hospital's care team in New Delhi, India, from initial consultation through recovery. Max Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.

4.8/5
Rating
2000
Established
500
Beds
New Delhi, India
Location
Narayana Health

🇮🇳 Narayana Health

Bengaluru, India 4.8 (1750 reviews) 1,000 beds
Why consider this hospital?
4.8/5 rating from 1750 reviews1,000 beds
Specialties & Accreditation
CardiacPediatric SurgeryCancer
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering alpha-1-antitrypsin deficiency can be cared for by Narayana Health's care team in Bengaluru, India, from initial consultation through recovery. Narayana Health, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.

4.8/5
Rating
2000
Established
1,000
Beds
Bengaluru, India
Location
Yashoda Hospitals, Hi-Tech City

🇮🇳 Yashoda Hospitals, Hi-Tech City

Hi-Tech City, Hyderabad, India 4.8 (742 reviews) 2,000 beds
Why consider this hospital?
4.8/5 rating from 742 reviews2,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsOrgan Transplant
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering alpha-1-antitrypsin deficiency can be cared for by Yashoda Hospitals, Hi-Tech City's care team in Hi-Tech City, Hyderabad, India, from initial consultation through recovery. Yashoda Hospitals, Hi-Tech City, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.

4.8/5
Rating
1989
Established
2,000
Beds
Hi-Tech City, Hyderabad, India
Location

Top Liver Transplant & HPB Doctors in India

Image not available Featured

Dr. Abhideep Chaudhary

MBBS, MS (General Surgery), FACS, FAIS, FRCS (Glasgow), Multiorgan Transplant Surgery Fellowship
Chairman & HOD — HPB Surgery and Liver Transplantation · Specialty: HPB & Liver Transplant Surgeon
BLK-Max Super Speciality Hospital New Delhi, India22+ Years experience
Why consider this doctor?
  • 22+ years of experience in HPB & Liver Transplant Surgeon
  • Chairman & HOD — HPB Surgery & Liver Transplantation, BLK-Max Super Speciality Hospital, New Delhi
  • Associate Director & Head — Surgical Gastroenterology and Liver Transplantation, Jaypee Hospital, Noida
Expertise & Procedures
  • Living Donor Liver Transplant (LDLT)
  • Deceased Donor Liver Transplant (DDLT)
  • Robotic Donor Hepatectomy
  • Paediatric Liver Transplant
  • ABO-Incompatible Liver Transplant
View all procedures →
HPB & Liver Transplant Surgeon Experience: 22+ YearsHospital Affiliation: BLK-Max Super Speciality HospitalHospital accreditation: JCI, NABH
Image not available

Dr. Giriraj Bora

MBBS, MS (General Surgery), M.Ch (GI Surgery), Fellowship in Liver Transplant
Chief — Liver Transplant; Sr. Consultant — GI & HPB Surgery · Specialty: Liver Transplant & HPB Surgeon
Artemis Hospital Gurgaon, India20+ Years experience
Why consider this doctor?
  • 20+ years of experience in Liver Transplant & HPB Surgeon
  • Chief — Liver Transplant; Sr. Consultant — GI & HPB Surgery, Artemis Hospital, Gurugram
  • Consultant — Liver Transplant, Centre for Liver and Biliary Sciences (CLBS), New Delhi
Expertise & Procedures
  • Living Donor Liver Transplant (LDLT)
  • Deceased Donor Liver Transplant (DDLT)
  • ABO-Incompatible Liver Transplant
  • Combined Liver-Kidney Transplantation
  • Whipple Procedure (Pancreaticoduodenectomy) with Portal Vein Reconstruction
View all procedures →
Liver Transplant & HPB Surgeon Experience: 20+ YearsHospital Affiliation: Artemis HospitalHospital accreditation: JCI, NABH
Dr. Arvinder Singh Soin

Dr. Arvinder Singh Soin

MBBS, MS (Surgery), Primary FRCS, FRCS (Edinburgh), FRCS (Glasgow), FRCS (Gen Surg)
Chairman — Liver Transplant · Specialty: Liver Transplant & HPB Surgeon
Medanta – The Medicity Gurugram, India36+ Years experience
Why consider this doctor?
  • 36+ years of experience in Liver Transplant & HPB Surgeon
  • Chairman — Liver Transplant, Medanta – The Medicity, Gurugram
  • Founder and Head — Liver Transplant Programme, Indraprastha Apollo Hospitals, New Delhi
Expertise & Procedures
  • Living donor liver transplantation (LDLT)
  • Deceased donor liver transplantation (DDLT)
  • ABO-incompatible liver transplantation
  • Split liver transplantation
  • Paediatric liver transplantation
View all procedures →
Liver Transplant & HPB Surgeon Experience: 36+ YearsHospital Affiliation: Medanta – The MedicityHospital accreditation: JCI, NABH
Image not available

Dr. Ameet Mandot

MBBS, MD, DNB, Fellowship in Hepatology & Liver Transplantation
Director & Clinical Lead — Adult Hepatology & Liver Transplant · Specialty: Hepatologist & Liver Transplant Specialist
Gleneagles Hospital, Mumbai Mumbai, India24+ Years experience
Why consider this doctor?
  • 24+ years of experience in Hepatologist & Liver Transplant Specialist
  • Director & Clinical Lead — Adult Hepatology & Liver Transplant, Gleneagles Hospital, Mumbai — Present
  • Academic Head, Department of Gastroenterology, Bombay Hospital, Mumbai
Expertise & Procedures
  • Liver Transplantation (Orthotopic and Living Donor)
  • Endoscopic Retrograde Cholangiopancreatography (ERCP)
  • Endoscopic Variceal Ligation and Sclerotherapy
  • Transjugular Intrahepatic Portosystemic Shunt (TIPS)
  • Ascitic Tap and Management of Refractory Ascites
View all procedures →
Hepatologist & Liver Transplant Specialist Experience: 24+ YearsHospital Affiliation: Gleneagles Hospital, MumbaiHospital accreditation: NABH, JCI
Image not available

Dr. Amit Chopde

MBBS, DNB (General Surgery), DNB (Surgical Gastroenterology), HBNI Fellowship (GI and HPB Onco Surgery), Fellowship (HPB and Liver Transplant Surgery)
Consultant — Surgical Gastroenterology · Specialty: Hepatobiliary & Pancreatic Surgeon
Gleneagles Hospital Mumbai, India12+ Years experience
Why consider this doctor?
  • 12+ years of experience in Hepatobiliary & Pancreatic Surgeon
  • Consultant, Surgical Gastroenterology — Gleneagles Hospital, Mumbai, Present
  • Assistant Professor and Consultant, Department of HPB & GI Oncology — Tata Memorial Hospital, Mumbai
Expertise & Procedures
  • Liver transplant evaluation and management
  • Hepatic resection for cancer and benign tumors
  • Whipple procedure (pancreaticoduodenectomy)
  • Distal and total pancreatectomy
  • Robotic hepatobiliary and pancreatic surgery
View all procedures →
Hepatobiliary & Pancreatic Surgeon Experience: 12+ YearsHospital Affiliation: Gleneagles HospitalHospital accreditation: NABH, JCI
Image not available

Dr. Amit Jha

MBBS, MD (Anaesthesia)
Senior Consultant & Head — Liver Transplant & GI Surgery Anaesthesia · Specialty: Liver Transplant Anaesthesiologist
Paras Hospitals Gurugram, India16+ Years experience
Why consider this doctor?
  • 16+ years of experience in Liver Transplant Anaesthesiologist
  • Senior Consultant & Head – Liver Transplant & GI Surgery Anaesthesia, Paras Hospitals, Gurugram
  • Specialist in Transplant Anaesthesia – Liver Transplant & HPB Surgery unit, Paras Hospitals, Gurugram
Expertise & Procedures
  • Liver transplant anaesthesia and perioperative management
  • Deceased donor liver transplant
  • Living donor liver transplant
  • Pediatric liver transplant
  • Liver retransplantation
View all procedures →
Liver Transplant Anaesthesiologist Experience: 16+ YearsHospital Affiliation: Paras HospitalsHospital accreditation: NABH, NABL
Our Methodology

How we selected these hospitals

A hospital appears on this page when Liver Transplant & HPB is among its listed specialties and it is located in India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Alpha-1-Antitrypsin Deficiency in India?

Choosing the right hospital for alpha-1-antitrypsin deficiency is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include liver transplant & hpb rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Alpha-1-Antitrypsin Deficiency

Alpha-1-Antitrypsin Deficiency (AATD) is a serious inherited metabolic disorder that leads to progressive emphysema and liver disease; AAT augmentation therapy (intravenous infusion of purified human alpha-1-antitrypsin) is the only disease-modifying treatment proven to slow lung function decline in Pi*ZZ and related phenotypes, with clinical studies demonstrating a statistically significant reduction in CT-measured lung density loss and annual FEV1 decline.

1–2 days per infusion cycle (outpatient or short-stay); 5–10 days for initial diagnostic work-up and therapy induction if travelling internationally
Hospital Stay
1–2 weeks for initial evaluation, therapy initiation, and tolerance monitoring before international travel home; ongoing therapy requires return visits every 4–8 weeks or coordination with a home infusion provider
Total Stay in Country (Fit-to-Fly)
Augmentation therapy reduces annual CT lung density decline by approximately 34% compared to placebo (RAPID trial data); liver-directed therapies (RNA interference, gene therapy trials) show 80–95% target engagement in early-phase studies. Overall treatment response (stabilisation of lung function trajectory) is documented in 70–85% of compliant patients.
Success Rate

Clinical Overview

  • Alpha-1-Antitrypsin Deficiency (AATD) is an autosomal co-dominant genetic disorder caused by mutations in the SERPINA1 gene, most commonly the Pi*Z (Glu342Lys) allele.
  • The resulting misfolded AAT protein is retained within hepatic endoplasmic reticulum, reducing circulating AAT to less than 11 µmol/L — far below the protective threshold of 35 µmol/L needed to neutralise neutrophil elastase in alveolar tissue.
  • The unopposed elastase activity progressively destroys alveolar walls, producing panlobular emphysema with a characteristic basal predominance on high-resolution CT (HRCT).
Full details →

Who is a Candidate?

  • CONFIRMED PHENOTYPE: Pi*ZZ, Pi*ZNull, Pi*SZ, or other severe AATD genotypes confirmed by serum AAT level (< 11 µmol/L or < 57 mg/dL by nephelometry) AND SERPINA1 genotyping or isoelectric focusing (IEF)
  • PULMONARY ELIGIBILITY FOR AUGMENTATION: FEV1 15–65% predicted on spirometry; CT-documented emphysema (quantitative PD15 densitometry); non-smoker or smoking cessation confirmed ≥ 6 months; absence of IgA deficiency (risk of anaphylaxis to plasma products)
  • LIVER DISEASE EVALUATION: All AATD patients require baseline liver assessment — serum LFTs, FibroScan® (liver stiffness ≥ 7 kPa warrants enhanced surveillance), abdominal ultrasound, and AFP for HCC screening in cirrhotic patients
  • REQUIRED PRE-TREATMENT DIAGNOSTICS: Full pulmonary function tests (spirometry, body plethysmography, DLCO); HRCT thorax with quantitative densitometry; 6-minute walk test (6MWT) and SGRQ-C quality-of-life score; echocardiography (ECHO) to exclude pulmonary hypertension (RVSP > 40 mmHg modifies transplant candidacy); complete blood count, coagulation profile, serum protein electrophoresis; hepatitis B/C serology and HIV screening
  • +4 more

Treatment Options & Approaches

  • STANDARD AAT AUGMENTATION THERAPY (INTRAVENOUS): Weekly IV infusion of purified, pasteurised, human plasma-derived alpha-1-antitrypsin concentrate at 60 mg/kg body weight, administered over 15–30 minutes in an outpatient or day-care setting.
  • This is the only FDA-approved, EMA-approved disease-modifying therapy for AATD-related emphysema.
  • The RAPID and RAPID-OLE trials (the only double-blind, placebo-controlled studies in AATD) demonstrated a 34% reduction in annual CT lung density loss (PD15 endpoint) and a significant benefit in FEV1 decline in the treatment arm over 4 years.

Recovery

  • PHASE 1 — PRE-ARRIVAL PREPARATION (2–4 weeks before travel):

Risks to be aware of

  • AAT augmentation therapy has an established safety profile across three decades of clinical use, but patients and clinicians must consider the following specific risks and limitations:
Full details →

Why GAF Healthcare

  • GAF Healthcare provides a fully integrated non-medical support infrastructure designed to eliminate barriers to international treatment access for AATD patients:

Common questions about Alpha-1-Antitrypsin Deficiency

What is the cost of Alpha-1-Antitrypsin Deficiency Treatment (AAT Augmentation Therapy) in India versus the UAE?
An initial international treatment visit to India — covering comprehensive AATD diagnostic confirmation (spirometry, quantitative HRCT, FibroScan®, SERPINA1 genotyping, full blood panel), MDT consultations, and initiation of AAT augmentation therapy (2 supervised infusions) — costs approximately USD 2,500 to USD 6,000 at JCI- and NABH-accredited hospitals in Mumbai, Delhi, or Chennai. Equivalent treatment at JCI- and DHA-accredited hospitals in Dubai or Abu Dhabi typically ranges from USD 5,000 to USD 12,000 for the same scope of care. This represents a cost saving of 40–60% in India versus the UAE. It is important to note that AAT augmentation therapy is a lifelong weekly infusion; the cost of ongoing therapy once the patient returns home depends on local pharmaceutical pricing and insurance coverage. For surgical interventions — endobronchial valve lung volume reduction (approximately USD 8,000–15,000 in India vs. USD 18,000–30,000 in UAE) or bilateral lung transplantation (approximately USD 40,000–75,000 in India vs. USD 120,000–200,000 in UAE) — GAF Healthcare provides itemised cost estimates following clinical evaluation. All quoted ranges are inclusive of hospital stay, standard medications, nursing care, and standard investigative procedures.
How long do I need to stay in India or the UAE before I am fit to fly home after starting AAT Augmentation Therapy?
For patients travelling internationally to initiate AAT augmentation therapy, the recommended minimum in-country stay is 10 to 14 days. The first 3 days are dedicated to comprehensive baseline diagnostics and MDT review. Therapy is initiated on Day 4 with the first IV infusion, followed by a second infusion approximately 7 days later. A minimum 60-minute post-infusion observation period is required after each infusion to monitor for hypersensitivity reactions. Flight clearance is issued by the treating pulmonologist once two infusions have been tolerated without adverse events, the patient's SpO2 is ≥ 92% on room air at rest, and no acute pulmonary exacerbation is occurring. Patients with baseline resting SpO2 below 92% must undergo a hypoxia altitude simulation test (HAST) to determine whether in-flight supplemental oxygen (typically 2 L/min via nasal cannula) is required — this adds 1–2 days to the pre-departure timeline. For patients undergoing endobronchial valve (BLVR) procedures, the in-country stay is typically 7–10 days post-procedure given the 10–14% pneumothorax risk in the first 72 hours. Lung or liver transplant recipients require a minimum 4–8 weeks in-country post-surgery before international travel clearance.
What is the success rate of AAT Augmentation Therapy and related AATD treatments?
Success rates vary by treatment modality and the outcome measure used. For AAT augmentation therapy, the landmark RAPID and RAPID-OLE double-blind placebo-controlled trials demonstrated a 34% reduction in annual CT lung density loss (PD15 endpoint) compared to placebo over 2–4 years — the most objective and validated measure of disease-modifying efficacy in AATD emphysema. Augmentation therapy stabilises lung function trajectory in approximately 70–85% of compliant patients, with the greatest benefit seen in those with FEV1 between 35–65% predicted. The therapy does not reverse existing emphysema but significantly slows progression. For endobronchial lung volume reduction (Zephyr valves), the LIBERATE trial demonstrated a mean FEV1 improvement of 14.6% above placebo at 12 months, with 47% of treated patients achieving a clinically meaningful response (MCID ≥ 15% FEV1 improvement). For bilateral lung transplantation in AATD, the ISHLT registry reports 1-year survival of 80–85% and 5-year survival of 50–60%, which is among the better outcomes of all COPD indications for transplant. Liver transplantation for AATD-related cirrhosis achieves 1-year graft survival of 85–90% at high-volume centres in India. Emerging RNA interference therapies (fazirsiran) have shown 80–90% reduction in hepatic Z-AAT polymer in Phase 2 trials, with liver fibrosis stabilisation or improvement in the majority of participants. GAF Healthcare partner centres in India and the UAE report outcomes consistent with or superior to published international benchmarks, supported by prospective outcome tracking and participation in the Alpha-1 International Registry (AIR).

How GAF Healthcare Assists in Choosing the Best Hospital for Alpha-1-Antitrypsin Deficiency in India

Discover the Top Hospitals for Alpha-1-Antitrypsin Deficiency in India

This page lists 90 accredited liver transplant & hpb hospitals in India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Patient Success Story

Iraqi Family's Journey: Baby Ibrahim's Life-Saving Heart Surgery in India
Common Questions

Frequently asked questions about alpha-1-antitrypsin deficiency in India

How many liver transplant & hpb hospitals are listed in India?
90 hospitals in our India directory are currently listed for liver transplant & hpb including Alpha-1-Antitrypsin Deficiency.
How do you choose which hospitals to list?
A hospital appears on this page when Liver Transplant & HPB is among its listed specialties and it is located in India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Which cities in India have liver transplant & hpb hospitals listed?
Mumbai, Delhi NCR, Bengaluru, Hyderabad, Chennai. Use the city links on this page to view hospitals in a specific city.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including JCI, NABH, ISO, NABL — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for alpha-1-antitrypsin deficiency?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about alpha-1-antitrypsin deficiency in India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for alpha-1-antitrypsin deficiency in India.

Contact us to report an inaccuracy on this page.